A drug with the SMILES COc1c(N2CCN(C(=S)NC3CC4CCC3C4)C(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12 has a hERG inhibition at a concentration of 10uM of -11.359%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
COc1c(N2CCN(C(=S)NC3CC4CCC3C4)C(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
COc1c(N2CCN(C(=S)NC3CC4CCC3C4)C(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
7-[4-(2-bicyclo[2.2.1]heptanylcarbamothioyl)-3-methylpiperazin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid